Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: Implications for clinical management

Annemarie M.J. Wensing, David A. Van De Vijver, Gioacchino Angarano, Birgitta Åsjö, Claudia Balotta, Enzo Boeri, Ricardo Camacho, Maire Laure Chaix, Dominique Costagliola, Andrea De Luca, Inge Derdelinckx, Zehava Grossman, Osamah Hamouda, Angelos Hatzakis, Robert Hemmer, Andy Hoepelman, Andrzej Horban, Klaus Korn, Claudia Kücherer, Thomas LeitnerClive Loveday, Eilidh MacRae, Irina Maljkovic, Carmen De Mendoza, Laurence Meyer, Claus Nielsen, Eline L. Op De Coul, Vidar Ormaasen, Dimitris Paraskevis, Luc Perrin, Elisabeth Puchhammer-Stöckl, Lidia Ruiz, Mika Salminen, Jean Claude Schmit, Francois Schneider, Rob Schuurman, Vincent Soriano, Grzegorz Stanczak, Maja Stanojevic, Anne Mieke Vandamme, Kristel Van Laethem, Michela Violin, Karin Wilbe, Sabine Yerly, Maurizio Zazzi, Charles A. Boucher*

*Corresponding author for this work

Research output: Contribution to journalArticleResearchpeer-review

373 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: Implications for clinical management'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience